• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 的 C 末端结构域协调 PARP1 通过非共价和共价聚(ADP-核糖基)化 p53 之间的相互作用。

The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.

机构信息

Department of Biology, University of Konstanz, 78457 Konstanz, Germany.

Konstanz Research School Chemical Biology, University of Konstanz, 78457 Konstanz, Germany.

出版信息

Nucleic Acids Res. 2018 Jan 25;46(2):804-822. doi: 10.1093/nar/gkx1205.

DOI:10.1093/nar/gkx1205
PMID:29216372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5778597/
Abstract

The post-translational modification poly(ADP-ribosyl)ation (PARylation) plays key roles in genome maintenance and transcription. Both non-covalent poly(ADP-ribose) binding and covalent PARylation control protein functions, however, it is unknown how the two modes of modification crosstalk mechanistically. Employing the tumor suppressor p53 as a model substrate, this study provides detailed insights into the interplay between non-covalent and covalent PARylation and unravels its functional significance in the regulation of p53. We reveal that the multifunctional C-terminal domain (CTD) of p53 acts as the central hub in the PARylation-dependent regulation of p53. Specifically, p53 bound to auto-PARylated PARP1 via highly specific non-covalent PAR-CTD interaction, which conveyed target specificity for its covalent PARylation by PARP1. Strikingly, fusing the p53-CTD to a protein that is normally not PARylated, renders this a target for covalent PARylation as well. Functional studies revealed that the p53-PAR interaction had substantial implications on molecular and cellular levels. Thus, PAR significantly influenced the complex p53-DNA binding properties and controlled p53 functions, with major implications on the p53-dependent interactome, transcription, and replication-associated recombination. Remarkably, this mechanism potentially also applies to other PARylation targets, since a bioinformatics analysis revealed that CTD-like regions are highly enriched in the PARylated proteome.

摘要

翻译后的文本

翻译后内容

翻译后文本

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/26f7995ecd2b/gkx1205fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/fea0813bcc91/gkx1205fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/4cd49845e757/gkx1205fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/f2ec708513fe/gkx1205fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/db9f2400274c/gkx1205fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/9f9e1b9116a5/gkx1205fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/8d7bf35fa304/gkx1205fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/26f7995ecd2b/gkx1205fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/fea0813bcc91/gkx1205fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/4cd49845e757/gkx1205fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/f2ec708513fe/gkx1205fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/db9f2400274c/gkx1205fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/9f9e1b9116a5/gkx1205fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/8d7bf35fa304/gkx1205fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d91/5778597/26f7995ecd2b/gkx1205fig7.jpg

相似文献

1
The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.p53 的 C 末端结构域协调 PARP1 通过非共价和共价聚(ADP-核糖基)化 p53 之间的相互作用。
Nucleic Acids Res. 2018 Jan 25;46(2):804-822. doi: 10.1093/nar/gkx1205.
2
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.聚(ADP-核糖)化由 PARP1 介导:反应机制和调节蛋白。
Nucleic Acids Res. 2019 May 7;47(8):3811-3827. doi: 10.1093/nar/gkz120.
3
The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.PARP1 的神秘功能:从 PAR 化酶活性到 PAR 阅读蛋白。
Cells. 2019 Dec 12;8(12):1625. doi: 10.3390/cells8121625.
4
Poly(ADP-ribosyl)ation of OVOL2 regulates aneuploidy and cell death in cancer cells.OVOL2 的聚(ADP-核糖)化调节癌细胞的非整倍体和细胞死亡。
Oncogene. 2019 Apr;38(15):2750-2766. doi: 10.1038/s41388-018-0615-3. Epub 2018 Dec 12.
5
Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection.端粒蛋白 TIMESLESS 的多聚 ADP 核糖基化限制 DNA 复制应激并促进停滞叉的保护。
Cell Rep. 2024 Mar 26;43(3):113845. doi: 10.1016/j.celrep.2024.113845. Epub 2024 Feb 22.
6
Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.Y 盒结合蛋白 1 对聚(ADP-核糖)聚合酶 1 活性的调节。
Biomolecules. 2020 Sep 16;10(9):1325. doi: 10.3390/biom10091325.
7
Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy.通过 ATR-FTIR 光谱实时监测 PARP1 依赖性 PAR 化。
Nat Commun. 2020 May 1;11(1):2174. doi: 10.1038/s41467-020-15858-w.
8
Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.聚(ADP-核糖)聚合酶1和聚(ADP-核糖)在调节WRN和RECQL5活性中的差异作用与协同作用
Mol Cell Biol. 2015 Dec;35(23):3974-89. doi: 10.1128/MCB.00427-15. Epub 2015 Sep 21.
9
Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage.PARP1 对乙酰基转移酶 NAT10 的多聚(ADP-核糖基)化对于其核质易位以及在 DNA 损伤反应中的功能是必需的。
Cell Commun Signal. 2022 Aug 19;20(1):127. doi: 10.1186/s12964-022-00932-1.
10
The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.由PARP1介导的FoxO3多聚(ADP-核糖)化参与异丙肾上腺素诱导的心肌肥大。
Biochim Biophys Acta. 2016 Dec;1863(12):3027-3039. doi: 10.1016/j.bbamcr.2016.09.019.

引用本文的文献

1
Deciphering the dark side of histone ADP-ribosylation: what structural features of damaged nucleosome regulate the activities of PARP1 and PARP2.解读组蛋白ADP核糖基化的阴暗面:受损核小体的哪些结构特征调节PARP1和PARP2的活性。
Nucleic Acids Res. 2025 Sep 5;53(17). doi: 10.1093/nar/gkaf864.
2
Molecular Targets for Pharmacotherapy of Head and Neck Squamous Cell Carcinomas.头颈部鳞状细胞癌药物治疗的分子靶点
Curr Issues Mol Biol. 2025 Aug 1;47(8):609. doi: 10.3390/cimb47080609.
3
Adenosine diphosphate-ribosylation greatly affects proteins function: a focus on neurodegenerative diseases.

本文引用的文献

1
Serine ADP-Ribosylation Depends on HPF1.丝氨酸ADP核糖基化依赖于HPF1。
Mol Cell. 2017 Mar 2;65(5):932-940.e6. doi: 10.1016/j.molcel.2017.01.003. Epub 2017 Feb 9.
2
Proteome-wide identification of the endogenous ADP-ribosylome of mammalian cells and tissue.哺乳动物细胞和组织内源性ADP-核糖基化组的全蛋白质组鉴定。
Nat Commun. 2016 Sep 30;7:12917. doi: 10.1038/ncomms12917.
3
The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.摇尾之尾:无序的C末端结构域如何控制p53肿瘤抑制蛋白的转录活性。
二磷酸腺苷核糖基化对蛋白质功能有很大影响:聚焦神经退行性疾病。
Front Aging Neurosci. 2025 Apr 30;17:1575204. doi: 10.3389/fnagi.2025.1575204. eCollection 2025.
4
Proteome-wide microarray-based screening of PAR-binding proteins.基于蛋白质组芯片的PAR结合蛋白全蛋白质组筛选。
Nucleic Acids Res. 2025 Apr 10;53(7). doi: 10.1093/nar/gkaf300.
5
p53-deficient cancer cells hyperactivate DNA double-strand break repair pathways to overcome chemotherapeutic damage and augment survival.p53基因缺陷的癌细胞过度激活DNA双链断裂修复途径,以克服化疗损伤并提高生存率。
Mol Biol Rep. 2025 Mar 22;52(1):333. doi: 10.1007/s11033-025-10434-1.
6
Nicotinamide mononucleotide combined with PJ-34 protects microglial cells from lipopolysaccharide-induced mitochondrial impairment through NMNAT3-PARP1 axis.烟酰胺单核苷酸联合PJ-34通过NMNAT3-PARP1轴保护小胶质细胞免受脂多糖诱导的线粒体损伤。
J Transl Med. 2025 Mar 6;23(1):279. doi: 10.1186/s12967-025-06280-1.
7
PARPs and ADP-ribosylation-mediated biomolecular condensates: determinants, dynamics, and disease implications.聚(ADP-核糖)聚合酶与ADP-核糖基化介导的生物分子凝聚物:决定因素、动力学及疾病影响
Trends Biochem Sci. 2025 Mar;50(3):224-241. doi: 10.1016/j.tibs.2024.12.013. Epub 2025 Feb 7.
8
Prognostic Significance of S100A4 in Ovarian Clear Cell Carcinoma: Its Relation to Tumor Progression and Chemoresistance.S100A4在卵巢透明细胞癌中的预后意义:其与肿瘤进展和化疗耐药性的关系
Cancers (Basel). 2025 Jan 8;17(2):184. doi: 10.3390/cancers17020184.
9
SART1 modulates poly-(ADP-ribose) chain accumulation and PARP1 chromatin localization.SART1调节聚(ADP - 核糖)链的积累和PARP1在染色质上的定位。
iScience. 2024 Oct 24;27(11):111252. doi: 10.1016/j.isci.2024.111252. eCollection 2024 Nov 15.
10
p53-dependent crosstalk between DNA replication integrity and redox metabolism mediated through a NRF2-PARP1 axis.p53 依赖性 DNA 复制完整性与氧化还原代谢之间的串扰通过 NRF2-PARP1 轴介导。
Nucleic Acids Res. 2024 Nov 11;52(20):12351-12377. doi: 10.1093/nar/gkae811.
Trends Biochem Sci. 2016 Dec;41(12):1022-1034. doi: 10.1016/j.tibs.2016.08.011. Epub 2016 Sep 23.
4
Nuclear translocation of annexin 1 following oxygen-glucose deprivation-reperfusion induces apoptosis by regulating Bid expression via p53 binding.氧糖剥夺-再灌注后膜联蛋白1的核转位通过p53结合调节Bid表达诱导细胞凋亡。
Cell Death Dis. 2016 Sep 1;7(9):e2356. doi: 10.1038/cddis.2016.259.
5
ADPriboDB: The database of ADP-ribosylated proteins.ADPriboDB:ADP-核糖基化蛋白质数据库。
Nucleic Acids Res. 2017 Jan 4;45(D1):D204-D209. doi: 10.1093/nar/gkw706. Epub 2016 Aug 9.
6
Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro.聚(ADP-核糖)聚合酶在体外共价修饰DNA片段中的链断裂末端。
Nucleic Acids Res. 2016 Nov 2;44(19):9279-9295. doi: 10.1093/nar/gkw675. Epub 2016 Jul 28.
7
DNA damage tolerance pathway involving DNA polymerase ι and the tumor suppressor p53 regulates DNA replication fork progression.涉及DNA聚合酶ι和肿瘤抑制因子p53的DNA损伤耐受途径调控DNA复制叉的进展。
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):E4311-9. doi: 10.1073/pnas.1605828113. Epub 2016 Jul 12.
8
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.p53 通路:起源、癌症中的失活以及新兴治疗方法。
Annu Rev Biochem. 2016 Jun 2;85:375-404. doi: 10.1146/annurev-biochem-060815-014710. Epub 2016 May 4.
9
PARP1 Links CHD2-Mediated Chromatin Expansion and H3.3 Deposition to DNA Repair by Non-homologous End-Joining.聚(ADP-核糖)聚合酶1(PARP1)将CHD2介导的染色质扩张和H3.3沉积与非同源末端连接的DNA修复联系起来。
Mol Cell. 2016 Feb 18;61(4):547-562. doi: 10.1016/j.molcel.2016.01.019.
10
Readers of poly(ADP-ribose): designed to be fit for purpose.聚(ADP - 核糖)的读者:旨在符合目的。
Nucleic Acids Res. 2016 Feb 18;44(3):993-1006. doi: 10.1093/nar/gkv1383. Epub 2015 Dec 15.